Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 123Head and Neck Neoplasms 80Oropharyngeal Neoplasms 19Carcinoma, Non-Small-Cell Lung 15Laryngeal Neoplasms 13Carcinoma, Squamous Cell 13Salivary Gland Neoplasms 12Carcinoma 12Mouth Neoplasms 11Ovarian Neoplasms 9Neoplasm Metastasis 9Nasopharyngeal Carcinoma 9Nasopharyngeal Neoplasms 8Esophageal Neoplasms 8Stomach Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Lung Neoplasms 6Hypopharyngeal Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Small Cell Lung Carcinoma 5Recurrence 5Papillomavirus Infections 5Melanoma 5Breast Neoplasms 5Urinary Bladder Neoplasms 4Tongue Neoplasms 4Sarcoma 4Pancreatic Neoplasms 4Esophageal Squamous Cell Carcinoma 4

Interventions

toripalimab 1Radiotherapy 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × Carboplatin × Head & Neck × Clear all
NCT06940180 2025-06-26

Toripalimab With Chemotherapy for Sinus Cancer

Dana-Farber Cancer Institute

Phase 2 Recruiting
20 enrolled
Head & Neck

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡